ORIGENE TECHNOLOGIES INC.
History
| Year | Detail |
|---|---|
| 1996 | In 1996, OriGene Technologies was founded as a research tool company focused on creating a sizeable commercial collection of full-length human cDNAs, which supply tools for gene-based research. |
| 2010 | OriGene developed mouse monoclonal antibodies against full-length human proteins as immunogens. These antibodies provide higher sensitivity and specificity than peptide-derived antibodies. |
| 2011 | The company developed a high-density protein microarray chip for antibody evaluation at the proteome-wide level. This chip is spotted with over 17,000 overexpression proteins in duplicate on a single nitrocellulose-coated glass slide and various positive and negative controls. |
| 2012 | OriGene developed a high-density protein microarray for antibody specificity testing, with the goal of solving antibody non-specificity and cross-reactivity issues in diagnostic assays. |
| 2013 | The company acquired SDIX, a life-sciences technology provider, for $16 million to develop a comprehensive collection of monoclonal antibodies for key applications in research and diagnostics. |
| 2015 | The company acquired Acris Antibodies GmbH, a Herford, Germany, and San Diego-based provider of antibodies and other life science-related products, to leverage its global reach to bring Acris products to a more extensive customer base. |
BCC Research Beacon 